Published in Blood Weekly, December 11th, 1995
For immunocompromised patients who are CMV seronegative, primary CMV infection transmitted by transfusion is a significant problem, noted Raleigh A. Bowden, Fred Hutchinson Cancer Research Center, Seattle, Washington, and colleagues.
For CMV seronegative BMT patients with CMV negative marrow donors, the transfusion of CMV seronegative blood products now is considered standard care.
Bowden et al....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.